Lecanemab shows 67% patient retention at 24 months in US study

Investing_ng | 21-03-2026 05:19am |

Lecanemab shows 67% patient retention at 24 months in US study

Related Articles

Stop Comparing Me With Your Faves For Cl... World
Rivers: So, why are we angry at Niger, M... Top
UniAbuja Acting VC Promises Transparency... Top
NAFDAC: Rethinking Strategy In The Fight... Top
South-South Governors’ Forum opposes e... Top
Kenya Reneges on IMF $3.6bn Deal, Forfei... Top

Stay Updated with the Latest News!

Don't miss out on breaking stories and in-depth articles.

See the latest News